GSK

October 24, 2018
RNAi Therapeutics Come of Age: Exploring the Peaks & Troughs of Alnylam's Thirty Year Journey to First Approval
Categories

RNAi Therapeutics Come of Age: Exploring the Peaks & Troughs of Alnylam’s Thirty Year Journey to First Approval

Do you like it?
Read more
January 23, 2018
Gene Therapy Manufacturing: An Impending Crisis or Temporary Growing Pains?
Categories

Gene Therapy Manufacturing: An Impending Crisis or Temporary Growing Pains?

Do you like it?
Read more
October 24, 2017
Monogenic Gene Therapies: Will Spark Therapeutics’ Luxturna Avoid the Fate of Glybera & Strimvelis?
Categories

Monogenic Gene Therapies: Will Spark Therapeutics’ Luxturna Avoid the Fate of Glybera & Strimvelis?

Do you like it?
Read more
August 25, 2017
Categories

The Future of BioManufacturing: The Promise of Perfusion

Do you like it?
Read more
February 21, 2016
Evolution Infographic: The Rise & Diversification of Biologics
Categories

Evolution Infographic: The Rise & Diversification of Biologics

For our latest Data Visualisation project, the Evolution Global Team analysed historical new drug approval statistics and the current clinical trials pipeline to identify trends that […]
Do you like it?
Read more
Contact Us